| |
| |
|
| Insider
Information: |
Pickering Grant |
| Relationship: |
Director |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
524,530 |
|
|
Indirect Shares
|
294,724 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
819,254 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Dendreon Corp |
DNDN |
Sr VP, Operations |
2005-03-18 |
45,900 |
|
0 |
Premium* |
|
|
Vaxcyte, Inc. |
PCVX |
|
2024-04-23 |
477,847 |
2024-04-23 |
294,724 |
Premium* |
|
|
Athira Pharma, Inc. |
ATHA |
Director |
2022-03-21 |
783 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-23 |
4 |
AS |
$61.92 |
$928,845 |
D/D |
(15,000) |
477,847 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-23 |
4 |
OE |
$1.79 |
$26,850 |
D/D |
15,000 |
492,847 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-04-01 |
4 |
AS |
$66.45 |
$174,502 |
I/I |
(2,616) |
147,362 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-25 |
4 |
AS |
$66.87 |
$1,003,978 |
D/D |
(15,000) |
477,847 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-25 |
4 |
OE |
$1.79 |
$26,850 |
D/D |
15,000 |
492,847 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-11 |
4 |
OE |
$2.03 |
$131,950 |
D/D |
65,000 |
477,847 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-02 |
4 |
D |
$71.55 |
$570,039 |
D/D |
(7,967) |
412,847 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-03-01 |
4 |
AS |
$72.97 |
$192,799 |
I/I |
(2,616) |
148,670 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-29 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
420,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-26 |
4 |
AS |
$79.03 |
$2,370,900 |
D/D |
(30,000) |
375,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-26 |
4 |
OE |
$1.79 |
$53,700 |
D/D |
30,000 |
405,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-23 |
4 |
AS |
$75.15 |
$1,143,206 |
D/D |
(15,000) |
375,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-23 |
4 |
OE |
$1.79 |
$26,850 |
D/D |
15,000 |
390,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-02-01 |
4 |
AS |
$71.93 |
$193,353 |
I/I |
(2,616) |
149,978 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-29 |
4 |
AS |
$66.03 |
$1,980,900 |
D/D |
(30,000) |
375,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-29 |
4 |
OE |
$1.79 |
$53,700 |
D/D |
30,000 |
405,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-23 |
4 |
AS |
$63.22 |
$958,783 |
D/D |
(15,000) |
375,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
CHIEF EXECUTIVE OFFICER |
• • – |
2024-01-23 |
4 |
OE |
$0.04 |
$21,600 |
D/D |
15,000 |
390,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2024-01-02 |
4 |
AS |
$62.91 |
$167,144 |
I/I |
(2,616) |
151,286 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-12-26 |
4 |
AS |
$61.32 |
$925,538 |
D/D |
(15,000) |
375,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-12-26 |
4 |
OE |
$0.04 |
$400 |
D/D |
10,000 |
390,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-12-22 |
4 |
OE |
$2.03 |
$20,097 |
D/D |
9,900 |
380,814 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-12-01 |
4 |
AS |
$51.43 |
$136,442 |
I/I |
(2,618) |
152,594 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-11-24 |
4 |
AS |
$48.96 |
$736,300 |
D/D |
(15,000) |
370,914 |
0 |
- |
|
| PCVX |
Vaxcyte, Inc. |
Chief Executive Officer |
• • – |
2023-10-23 |
4 |
AS |
$46.98 |
$706,070 |
D/D |
(15,000) |
385,914 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
